GeneNews’ JV IDL launches Beckman Coulter’s phi test across U.S.
GeneNews’ (TSX:GEN) recently formed joint venture, Innovative Diagnostic Laboratory, has added Beckman Coulter Diagnostics’ Prostate Health Index (phi) to its menu of advanced cancer assays and has...
View ArticlePHI test included in updated NCCN Guidelines
Beckman Coulter’s Prostate Health Index (PHI), which is offered in the U.S. by GeneNews’ (TSX:GEN) Innovation Diagnostic Lab (IDL) joint venture, has been recommended by the National Comprehensive...
View ArticleTransition licenses Phase 2 drug candidate from Lilly
Transition Therapeutics (NASDAQ:TTHI: TSX:TTH), through its wholly-owned subsidiary, Transition Therapeutics Ireland Ltd. (TTIL), has exclusively licensed worldwide rights to a novel small molecule...
View ArticleGeneNews’ IDL to provide prostate testing to MD Anderson
GeneNews’ (TSX:GEN) Innovative Diagnostic Laboratory (IDL) joint venture has agreed to provide its prostate health index (PHI) testing services to MD Anderson Cancer Center. “There is significant...
View Article
More Pages to Explore .....